22 May 2013
Keywords: relpax, cleared, usa, after, four-year, review, pfizer
Article | 06 January 2003
Pfizer's Relpax (eletriptan hydrobromide) has been approved in the USAfor the treatment of migraine headache after significant delays which
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 January 2003
© 2013 thepharmaletter.com